Cell Therapy Global Market Report 2022: Market is Expected to Reach $19.75 Billion in 2026 at a CAGR of 16.5% - Long-term Forecast to 2031 - ResearchAndMarkets.com

·4 min read

DUBLIN, May 20, 2022--(BUSINESS WIRE)--The "Cell Therapy Global Market Report 2022: By Technique, By Therapy, By Application" report has been added to ResearchAndMarkets.com's offering.

The global cell therapy market is expected to grow from $9.02 billion in 2021 to $10.74 billion in 2022 at a compound annual growth rate (CAGR) of 19%. The market is expected to reach $19.75 billion in 2026 at a CAGR of 16.5%.

Major players in the cell therapy market are Fibrocell Science Inc., JCR Pharmaceuticals Co. Ltd., PHARMICELL Co. Ltd., Osiris Therapeutics Inc., MEDIPOST, Vericel Corporation, Anterogen Co. Ltd., Kolon TissueGene Inc., Stemedica Cell Technologies Inc. and AlloCure.

The cell therapy market consists of sales of cell therapy and related services. Cell therapy (CT) helps repair or replace damaged tissues and cells. A variety of cells are used for the treatment of diseases includes skeletal muscle stem cells, hematopoietic (blood-forming) stem cells (HSC), lymphocytes, mesenchymal stem cells, pancreatic islet cells, and dendritic cells.

The main techniques used in cell therapy are stem cell therapy, cell vaccine, adoptive cell transfer (act), fibroblast cell therapy and chondrocyte cell therapy. Stem cell treatment, also known as regenerative medicine, uses stem cells or their derivatives to stimulate the healing response of sick, defective, or wounded tissue. The different types of therapies include allogeneic therapies, autologous therapies and is used in various applications such as oncology, cardiovascular disease (CVD), orthopedic, wound healing, others.

The rising prevalence of chronic diseases contributed to the growth of the cell therapy market. According to the US Centers for Disease Control and Prevention (CDC), chronic disease is a condition that lasts for one year or more and requires medical attention or limits daily activities or both and includes heart disease, cancer, diabetes, and Parkinson's disease.

Stem cells can benefit the patients suffering from spinal cord injuries, type 1 diabetes, Parkinson's disease (PD), heart disease, cancer, and osteoarthritis. For instance, according to the Center for Diseases Control and Prevention report in 2021, due to poor nutrition, and lack of physical activity, 6 in 10 adults in the USA are suffering from a chronic disease and 4 in 10 have two or more diseases.

According to International Diabetes Federation, in 2019, globally 463 million people have diabetes and the number is expected to rise to 700 million by 2045 . According to the Parkinson's Foundation, every year, 60,000 Americans are diagnosed with PD, and more than 10 million people are living with PD worldwide. The growing prevalence of chronic diseases increased the demand for cell therapies and contributed to the growth of the market.

The high cost of cell therapy hindered the growth of the cell therapy market. Cell therapies have become a common choice of treatment in recent years as people are looking for the newest treatment options. Although there is a huge increase in demand for cell therapies, they are still very costly to try. Therefore, the high cost of cell therapy restraints the growth of the cell therapy market.

Key players in the market are strategically partnering and collaborating to expand the product portfolio and geographical presence of the company.

Key Topics Covered:

1. Executive Summary

2. Cell Therapy Market Characteristics

3. Cell Therapy Market Trends And Strategies

4. Impact Of COVID-19 On Cell Therapy

5. Cell Therapy Market Size And Growth

5.1. Global Cell Therapy Historic Market, 2016-2021, $ Billion

5.1.1. Drivers Of The Market

5.1.2. Restraints On The Market

5.2. Global Cell Therapy Forecast Market, 2021-2026F, 2031F, $ Billion

5.2.1. Drivers Of The Market

5.2.2. Restraints On the Market

6. Cell Therapy Market Segmentation

6.1. Global Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Stem Cell Therapy

  • Cell Vaccine

  • Adoptive Cell Transfer (ACT)

  • Fibroblast Cell Therapy

  • Chondrocyte Cell Therapy

6.2. Global Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Allogeneic Therapies

  • Autologous Therapies

6.3. Global Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Oncology

  • Cardiovascular Disease (CVD)

  • Orthopedic

  • Wound Healing

  • Others

7. Cell Therapy Market Regional And Country Analysis

7.1. Global Cell Therapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7.2. Global Cell Therapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Companies Mentioned

  • Fibrocell Science Inc.

  • JCR Pharmaceuticals Co. Ltd.

  • PHARMICELL Co. Ltd.

  • Osiris Therapeutics inc.

  • MEDIPOST

  • Vericel Corporation

  • Anterogen Co. Ltd.

  • Kolon TissueGene inc.

  • Stemedica Cell Technologies Inc.

  • AlloCure

  • Arteriocyte Medical Systems

  • Athersys inc.

  • Baxter Healthcare Corporation

  • Bone Therapeutics

  • Celgene Corporation

  • Cell Medica

  • Cellerant Therapeutics

  • Forticell Bioscience

  • Mesoblast Ltd.

  • AlloSource

  • Holostem Terapie Avanzate S.r.l

  • Pharmicell Co. Ltd.

  • TiGenix (Takeda Pharmaceuticals)

  • Stempeutics Research Pvt. Ltd.

  • Nipro Corp.

  • Tego Science

  • Corestem inc.

  • Forticell Bioscience

  • Cellerant Therapeutics

  • Cells for Cells

For more information about this report visit https://www.researchandmarkets.com/r/x8usr1

View source version on businesswire.com: https://www.businesswire.com/news/home/20220520005256/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting

Latest Stories

  • Russia steps up attacks in Ukraine after landmark NATO summit

    Russia pressed on with its offensive in eastern Ukraine on Thursday after NATO branded Moscow the biggest "direct threat" to Western security and agreed plans to modernise Kyiv's beleaguered armed forces. Ukrainian authorities said they were trying to evacuate residents from the frontline eastern city of Lysychansk, the focus of Russia's attacks where about 15,000 people remained under relentless shelling. In the southern UKRAINE-CRISIS region, Ukrainian forces were fighting back with artillery strikes of their own, Oleskiy Arestovych, adviser to the Ukrainian president, said in a video posted online.

  • FOREX-Euro under pressure as inflation fears send investors to dollar haven

    The euro struggled to regain a footing on Thursday, having tumbled overnight against a resurgent U.S. dollar, which benefited from safe-haven demand on renewed worries about higher rates and a global recession. It also dropped to a fresh 7-1/2-year low versus the Swiss franc at 0.99663 francs, with the Alpine currency another beneficiary of safe-haven flows and also still basking in the afterglow of the Swiss National Bank's surprise rate cut two weeks ago. Christopher Wong, senior FX strategist at Maybank, attributed the euro's fall against the dollar to the market moving away from riskier assets after "central bankers warned of lasting inflation and that they would prioritise combating (it), resulting in broad dollar rebound overnight."

  • Steve Bannon Seeks 3-Month Trial Delay for Criminal Contempt of Congress Charges

    He says finding an impartial jury would be impossible amid the Jan. 6 congressional hearings

  • Duvall, Wright lead Braves over Phillies, now 21-5 in June

    Adam Duvall homered, Kyle Wright tossed seven sharp innings and the Atlanta Braves kept rolling this month, beating the Philadelphia Phillies 4-1 on Wednesday night. Matt Olson hit a pair of doubles and William Contreras and Michael Harris II also had RBIs for the Braves. Rhys Hoskins homered and doubled for Philadelphia, which played without star slugger Bryce Harper for the third straight game.

  • Cardi B Says She Wants a 'Tummy Tuck' as She's 'a Little Heavier Than Usual' Since Giving Birth to Her Son

    "I just don't like this extra little skin," Cardi B said in an Instagram Story on Wednesday

  • A Look At The Fair Value Of BikeExchange Limited (ASX:BEX)

    How far off is BikeExchange Limited ( ASX:BEX ) from its intrinsic value? Using the most recent financial data, we'll...

  • Air Canada to slash summer flight schedule as airports face lengthy delays

    MONTREAL — Air Canada is cutting more than 15 per cent of its scheduled flights in July and August as airports face lengthy delays and cancellations amid an overwhelming travel resurgence. The slimmed-down schedule will affect 154 flights per day on average, mainly from its Toronto and Montreal hubs, and all on domestic and Canada-U.S. routes, the company said in an email Wednesday. The shift is marked mainly by frequency reductions that affect evening and late-night flights on smaller planes, i

  • Asian shares end quarter in sombre mood, dollar on high

    Asian shares were ending a rough quarter in a sombre mood on Thursday amid fears central banks' cure for inflation will end up sickening the global economy, though it is proving to be a fillip for the safe-haven dollar and government bonds. Policy makers on Wednesday reiterated their commitment to controlling inflation no matter what pain it caused, and data on U.S. core prices later in the session will only underline the extent of the challenge. "Inflation can be sticky," warned analysts at ANZ.

  • R. Kelly sentenced to 30 years in prison after NY sex trafficking conviction

    A judge sentenced R. Kelly to 30 years in prison Wednesday after a jury found him guilty on nine counts of sex trafficking and racketeering.

  • Samsung Elec starts 3-nanometre chip production to lure new foundry customers

    Samsung Electronics Co Ltd said on Thursday it has begun mass producing chips with advanced 3-nanometre technology, the first to do so globally, as it seeks new clients to catch far bigger rival TSMC in contract chip manufacturing. Compared with conventional 5-nanometre chips, the newly developed first-gen 3-nanometre process can reduce power consumption by up to 45%, improve performance by 23%, and reduce area by 16%, Samsung said in a statement. The South Korean firm did not name clients for its latest foundry technology, which supplies made-to-order chips like mobile processors and high-performance computing chips, and analysts said Samsung itself and Chinese companies are expected to be among the initial customers.

  • Rory MacDonald says a change of scenery has led to ‘reinvented’ mindset, naturally more aggressive approach

    PFL welterweight Rory MacDonald has been more aggressive this season, and that's no accident.

  • Meghan Markle ‘bullying’ inquiry outcome to be kept secret by palace

    Meghan Markle was accused of driving out two personal assistants and of leaving some staff ‘humiliated’

  • Wild Rift Icons Knockout Stage: Which teams could make it to the finals?

    Eight teams remain in Wild Rift Icons, four of which are from the Chinese league. Here's our take on each of the remaining teams and their potential.

  • Global Website Builders Market Size to be worth US$ 3.5 Billion by 2032, PC Website Builders to flourish at over 6% CAGR: Fact.MR Study

    Rising Technological Advancements and Increasing Need of Online Portals For Businesses Is Stimulating Demand for Website Builders across Key GeographiesSeoul, South Korea, June 30, 2022 (GLOBE NEWSWIRE) -- The global website builders market is expected to reach US$ 3.5 Billion by the end of the 2022-2032 forecast period, growing at a CAGR of 6.9%, concludes a recently published report by Fact.MR. As of 2022, the market is poised to reach US$ 1.8 Billion, yielding a dollar opportunity worth US$ 1

  • Samsung Begins Chip Production Using 3nm Process Technology with GAA Architecture

    SEOUL, South Korea, June 30, 2022--Samsung Electronics Co., Ltd., the world leader in semiconductor technology, today announced that it has started initial production of its 3-nanometer (nm) process node applying Gate-All-Around (GAA) transistor architecture.

  • Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Including Corporate Reorganization

    Completed strategic review and announced intention to separate the Field Trip Discovery and Field Trip Health divisions into two independent public companies.Earned patient services revenues of $1.7 million in fiscal fourth quarter, an increase of 26.7% over the prior quarter and 228% year over year. Full year patient services revenue was $4.9 million, up from $0.96 million in the same period of the prior year.At March 31, 2022, Field Trip had approximately $63.7 million in unrestricted cash and

  • Hywin Holdings and FactSet Launch Global Health Care Index

    FactSet Hywin Global Health Care Index FactSet Hywin Global Health Care Index (FHGHC) Co-Branded Banner SHANGHAI, China and HONG KONG, June 30, 2022 (GLOBE NEWSWIRE) -- Hywin Holdings Ltd. ("Hywin Wealth", "Hywin", or the "Company") (NASDAQ: HYW), a leading independent wealth management service provider in China, and FactSet (NYSE: FDS) (NASDAQ: FDS), a global provider of integrated financial information, analytical applications, and industry-leading service, today announced the launch of FactSe

  • MedMira Reports Third Quarter Results FY2022

    HALIFAX, Nova Scotia, June 29, 2022 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended April 30, 2022. Profit and Loss Highlights Revenue: The Company recorded revenues in Q3 FY2022 of $323,925 compared to $64,631 for the same period last year. The increase in revenue in comparison with Q3 FY2021 was due to higher sales in for its Miriad®, Multiplo® and Reveal® product lines.Gross Profit: The Company recorded a gross profit in Q3

  • Man who killed Nipsey Hussle slashed with razor by inmates on his way to court

    Eric Holder, who has admitted to killing Nipsey Hussle, was jumped in a holding cell, his attorney said.

  • GLOBAL MARKETS-Asian shares end quarter in sombre mood, dollar on high

    Asian shares were ending a rough quarter in a sombre mood on Thursday amid fears central banks' cure for inflation will end up sickening the global economy, though it is proving to be a fillip for the safe-haven dollar and government bonds. The need for stimulus was underscored by data showing Japanese industrial output dived 7.2% in May, when analysts had looked for a dip of only 0.3%.